CytoLynx Therapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
CytoLynx Therapeutics General Information
Description
Operator of a research and commercialization platform intended to bring disruptive medicines to Greater China and worldwide. The company focuses on promoting a variety of NK therapies through product development.
Contact Information
Corporate Office
- Room A1302, 13th Floor, Building 3
- No.702 Zhongke Road, China (Shanghai) Pilot Free Trade Zone
- Shanghai
- China
Corporate Office
- Room A1302, 13th Floor, Building 3
- No.702 Zhongke Road, China (Shanghai) Pilot Free Trade Zone
- Shanghai
- China
CytoLynx Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CytoLynx Therapeutics Patents
CytoLynx Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4023673-A1 | Humanized monoclonal antibody targeting bcma and having human monkey cross-reactivity | Pending | 10-Oct-2019 | ||
| EP-4023673-A4 | Humanized monoclonal antibody targeting bcma and having human monkey cross-reactivity | Pending | 10-Oct-2019 | ||
| US-12479922-B2 | Humanized monoclonal antibody targeting bcma and having human monkey cross-reactivity | Active | 10-Oct-2019 | ||
| US-20240052048-A1 | Humanized monoclonal antibody targeting bcma and having human monkey cross-reactivity | Active | 10-Oct-2019 | C07K16/2878 |
CytoLynx Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
CytoLynx Therapeutics FAQs
-
When was CytoLynx Therapeutics founded?
CytoLynx Therapeutics was founded in 2021.
-
Where is CytoLynx Therapeutics headquartered?
CytoLynx Therapeutics is headquartered in Shanghai, China.
-
What industry is CytoLynx Therapeutics in?
CytoLynx Therapeutics’s primary industry is Biotechnology.
-
Is CytoLynx Therapeutics a private or public company?
CytoLynx Therapeutics is a Private company.
-
What is CytoLynx Therapeutics’s current revenue?
The current revenue for CytoLynx Therapeutics is .
-
Who are CytoLynx Therapeutics’s investors?
BioTrack Capital, Cytovia Therapeutics, Everbright ReinFore, Hangzhou Tigermed Consulting Company, and TF Capital are 5 of 6 investors who have invested in CytoLynx Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process